Company · CIK 0001693011
Inozyme Pharma, Inc.
Exchange
—
Entity type
operating
Fiscal year end
Dec 31
Headquarters
DE
Search this company’s filings
Search features10 guest searches · Free accounts get 10 a day · No credit card
On the record
Recent filings
- 8-KCurrent report0001193125-25-153582 · 322.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-143825 · 157.8 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-132782 · 141.4 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-121310 · 943.2 KBSEC(opens sec.gov)
- 10-QQuarterly update0000950170-25-070921 · 9.2 MBSEC(opens sec.gov)
- 8-KCurrent report0000950170-25-070917 · 509.4 KBSEC(opens sec.gov)
- 10-KAnnual report0000950170-25-035940 · 26.3 MBSEC(opens sec.gov)
- 8-KCurrent report0000950170-25-035939 · 301.2 KBSEC(opens sec.gov)
- 8-KCurrent report0001193125-25-004124 · 10.3 MBSEC(opens sec.gov)
- SC 13GInozyme Pharma, Inc.0001839882-24-044356 · 44.6 KBSEC(opens sec.gov)
Insiders
Tickers
No tickers on record.
Addresses
business
321 SUMMER STREET SUITE 400
BOSTON, MA, 02210
mailing
321 SUMMER STREET SUITE 400
BOSTON, MA, 02210
Former names
- Inozyme Pharma, LLC2017-01-05
Same industry